A total of 882 shares changed hands on the counter till 11:51AM (IST)
Global investors pull money out of Indian sovereign bonds for second week (21-10-2024)
Global funds last week sold Rs 870 crore ($104 million) of the so-called Fully Accessible Route bonds
Lower input costs may aid pharma firms’ Q2 margins (21-10-2024)
Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and amortisation) margins are anticipated to improve by about 110 basis points. Ebitda improvement will be led by lower input costs because prices of active pharmaceutical ingredients (APIs) are 5-15 per cent lower year-on-year (Y-o-Y). Axis Capital said sales growth would be around 10 per cent, of which growth in the India market would be 11 per cent or so.
Raymond Lifestyle stock jumps 4% after Motilal Oswal’s ‘buy’ rating (21-10-2024)
Revenue, profit to grow 11%, 15% CAGR between FY24 and FY27, says the brokerage
Pilani, Nalwa Sons, Tata Investment rally up to 17% in subdued market (21-10-2024)
Stock exchanges will conduct a special call auction for select investment holding companies on October 28 following the new framework introduced by the Sebi for price discovery.
Shares of PNB fall as Nifty drops (21-10-2024)
On the technical charts, the 200-day moving average of the stock stood at Rs 118.75.
Ujjivan Financial – Small Finance Bank (21-10-2024)
Thanks for sharing this